Pseudohypoaldosteronism: Clinical Trials

12 trials for Pseudohypoaldosteronism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 2 unknown, 1 active not recruiting, 1 recruiting. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1
Phase 31Completed 1

Follow Pseudohypoaldosteronism: new trials by email Literature Review of Pseudohypoaldosteronism trials Research Report on Pseudohypoaldosteronism

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Transient Pseudohypoaldosteronism Affecting Children With Urinary Tract Malformation
Pseudohypoaldosteronism
UnknownUniversity Hospital, Strasbourg, France502024-01-312025-04-01
Baby Detect : Genomic Newborn Screening
Congenital Adrenal Hyperplasia, Familial Hyperinsulinemic Hypoglycemia 1
CompletedCentre Hospitalier Universitaire de Liege68242022-09-012025-08-12
Survey Study and Records Review of Treatment Outcomes in Freeman-Sheldon Syndrome
Guided Health History for Freeman-Burian Syndrome Questionnaire, Freeman-Burian syndrome Semi-Structured Quality of Life Interview, Medical Records Review - Freeman-Burian Syndrome, Freeman-Sheldon Syndrome
UnknownDufresne, Craig, MD, PC202022-06-012022-07-19
Lokelma for RAAS Maximisation in CKD & Heart Failure.
Lokelma Oral Product - Chronic Kidney Diseases, Heart Failure With Reduced Ejection Fraction
Phase 3CompletedSt George's, University of London1122022-01-192026-04-27
Early Check: Expanded Screening in Newborns
Confirmatory Testing - Spinal Muscular Atrophy, Fragile X Syndrome
Active not recruitingRTI International300002018-10-152026-07-01
Survey Study and Records Review of Treatment Outcomes in Freeman-Sheldon Syndrome
PTSD Checklist-Civilian (PCL-C), Modified Flanagan Quality of Life Scale, Center for Epidemiologic Studies Depression Scale (CES-D) - Freeman-Sheldon Syndrome, Arthrogryposis Distal Type 2A
TerminatedFreeman-Sheldon Research Group, Inc.22010-02-012022-06-21
National Registry of Rare Kidney Diseases
Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis
RecruitingUK Kidney Association350002009-11-062023-10-04
Cardiovascular Evaluation of Adult PHA 1 Patients
Pseudohypoaldosteronism Type 1
CompletedAssistance Publique - Hôpitaux de Paris982008-05-012012-01-19
Genetic Disorders of Mucociliary Clearance in Nontuberculous Mycobacterial Lung Disease
Cystic Fibrosis, Pseudohypoaldosteronism
CompletedNational Heart, Lung, and Blood Institute (NHLBI)872006-10-172026-06-10
Rare Genetic Disorders of the Breathing Airways
Kartagener Syndrome, Cystic Fibrosis
CompletedUniversity of North Carolina, Chapel Hill3672006-05-012022-08-10
Studies of States With Resistance to Vitamin D and Parathyroid Hormone
Hypocalcemia, Pseudohypoparathyroidism
CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)701997-08-122023-01-20
Phase II Study of the Pathophysiology and Treatment With Enalapril and Polystyrene Sulfonate for Pseudohypoaldosteronism, Type I
enalapril, polystyrene sulfonate - Pseudohypoaldosteronism
Phase 2CompletedNational Center for Research Resources (NCRR)11992-12-012005-06-24

Narrower conditions

Cystic Fibrosis (4)  ·  Cystinosis (3)  ·  Granulomatous Disease, Chronic (3)  ·  Nephritis, Hereditary (3)  ·  3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency (2)  ·  Acidemia, isovaleric (2)  ·  Adenine phosphoribosyltransferase deficiency (2)  ·  Anemia, Sickle Cell (2)  ·  Argininosuccinic Aciduria (2)  ·  Arthrogryposis (2)  ·  Ataxia with vitamin E deficiency (2)  ·  Basal ganglia disease, biotin-responsive (2)  ·  Beta ketothiolase deficiency (2)  ·  Biotinidase Deficiency (2)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (12)  ·  Female Urogenital Diseases (12)  ·  Female Urogenital Diseases and Pregnancy Complications (12)  ·  Genetic Diseases, Inborn (12)  ·  Kidney Diseases (12)  ·  Male Urogenital Diseases (12)  ·  Renal Tubular Transport, Inborn Errors (12)  ·  Urogenital Diseases (12)  ·  Urologic Diseases (12)  ·  Congenital Abnormalities (7)  ·  Musculoskeletal Diseases (6)  ·  Pathologic Processes (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Abnormalities, Multiple (5)  ·  Disease Attributes (5)

Interventions

Health Records, Personal (2)  ·  Multicenter Studies as Topic (2)  ·  Enalapril (1)  ·  Metabolism (1)  ·  Surveys and Questionnaires (1)  ·  polystyrene sulfonic acid (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Centre Hospitalier Universitaire de Liege (1)  ·  Dufresne, Craig, MD, PC (1)  ·  Freeman-Sheldon Research Group, Inc. (1)  ·  National Center for Research Resources (NCRR) (1)  ·  National Heart, Lung, and Blood Institute (NHLBI) (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  RTI International (1)  ·  St George's, University of London (1)  ·  UK Kidney Association (1)  ·  University Hospital, Strasbourg, France (1)  ·  University of North Carolina, Chapel Hill (1)

Countries

United States (6)  ·  France (2)  ·  United Kingdom (2)  ·  Belgium (1)  ·  Canada (1)

Top investigators

Andrew J Lipton, M.D. (1)  ·  Bruce S. Keenan (1)  ·  Craig R Dufresne, MD (1)  ·  Curt Scharfe, MD, PhD (1)  ·  Debasish Banerjee, MD FRCP (1)  ·  Laurent Servais (1)  ·  Lee S Weinstein, M.D. (1)  ·  Michael R Knowles, MD (1)

Results publications

PMID 21514598, PMID 21926392, PMID 21926394, PMID 21926395, PMID 21926396, PMID 22177992, PMID 22184204, PMID 22276227, PMID 22328589, PMID 22499950, PMID 23040496, PMID 23477994, PMID 23852419, PMID 24577564, PMID 26494722, PMID 27070726, PMID 31315600, PMID 35142618, PMID 38072392

NIH funding

U54RR019480 (1)